Media Coverage

Break barriers to clinical trial participation

Reducing Barriers to Participation in Clinical Trials for Rare Disease

Research teams who appreciate the unique needs of rare disease patients and invest in a white-glove approach on behalf of trial participants can reduce barriers to participation. For sponsors, clinical study teams, and site staff, this means easier patient recruitment at the beginning of a study and fewer dropouts throughout the duration of the trial—with …

Reducing Barriers to Participation in Clinical Trials for Rare Disease Read More »

Patient Support Services to Facilitate Alzheimer’s Clinical Trials

Personalized Patient Support Services to Facilitate Alzheimer’s Clinical Trials Over 6.2 million Americans are living with Alzheimer’s disease. This number is expected to increase by 13 million in 2050. These numbers are daunting and will only continue to grow with time. Earlier this month, Clincierge’s CEO Scott Gray participated in an interview with MedicalResearch.com to …

Patient Support Services to Facilitate Alzheimer’s Clinical Trials Read More »

Patient Diversity in O&P trials

Achieving Diversity in O&P Clinical Trials: The Role of Support Services in Recruiting and Retaining O&P Patients

Achieving Diversity in Orthotic and Prosthetic Clinical Trials Logistical and financial barriers have created significant barriers to clinical trial participation, resulting in historical under-representation of minority populations in clinical trials. As the industry seeks to counter past shortcomings, sponsors in the O&P space must utilize proactive strategies to recruit diverse populations to ensure appropriate diversity. …

Achieving Diversity in O&P Clinical Trials: The Role of Support Services in Recruiting and Retaining O&P Patients Read More »

Clinical trial diversity

Achieving Clinical Trial Diversity Through Actionable Steps

The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and …

Achieving Clinical Trial Diversity Through Actionable Steps Read More »

Diversity In Clinical Trials Image

Diversity in Clinical Trials: Going Beyond Why to How

Diversity in Clinical Trials: Going Beyond Why to How Diversity is a hot-button issue within the global medical community. The industry continues to seek effective and sustainable solutions to create more diverse clinical trials. Our CEO, Scott Gray, joined Michael Causey, Editor-in-Chief, ACRP TV, to share his insight and practical methods for improving diversity in …

Diversity in Clinical Trials: Going Beyond Why to How Read More »

We are monitoring the impact of the COVID-19 Delta Variant on the travel and clinical trial industries.